NASDAQ
0.48USD
-0.30 (-38.85%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
270.7K
P/E
—
EPS
—
Beta
0.76
52W range
0.25-14.14
Day range
0.42–0.64
Open
0.56
Prev close
0.78
Volume
19.3M
Avg volume
5.5M
Dividend
0.00
IPO
2013-04-25
https://www.businesswire.com/news/home/20260729962665/en/L%C5%8Dkahi-Therapeutics%E2%84%A2-Advances-LT-100-Development-Strategy-Toward-Single-Injection-Administration/ · 7/29/2026+0.40
https://www.globenewswire.com/news-release/2026/07/14/3327361/0/en/Glucotrack-and-L%C5%8Dkahi-Therapeutics-Complete-Strategic-Business-Combination-Establishing-L%C5%8Dkahi-Controlled-Public-Platform.html · 7/14/2026+0.80
Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is available to customers both in Israel and across the globe. The company, founded in 2001, operated under the name Integrity Applications, Inc. until it officially rebranded to GlucoTrack, Inc. in November 2021.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
